Sorafenib-induced liver failure.
Schramm
Christoph
C
Schuch
Gunter
G
Lohse
Ansgar W
AW
D018263:Adenocarcinoma, Follicular / Q000188:drug therapy; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001557:Benzenesulfonates / Q000009:adverse effects*; D005260:Female; D006801:Humans; D017093:Liver Failure / Q000139:chemically induced* / Q000175:diagnosis / Q000628:therapy; D009536:Niacinamide / Q000031:analogs & derivatives; D010671:Phenylurea Compounds; D011725:Pyridines / Q000009:adverse effects*; D000077157:Sorafenib; D013964:Thyroid Neoplasms / Q000188:drug therapy
D000970:Antineoplastic Agents; D001557:Benzenesulfonates; D010671:Phenylurea Compounds; D011725:Pyridines; D009536:Niacinamide; D000077157:Sorafenib